Newborn ECMO is one of the most intense forms of life support a tiny human can be placed on. Doctors reach for it when a baby's heart or lungs cannot keep up with the body's needs, even after maximum ventilator and drug therapy. The machine pulls blood out of the baby, pushes it through an artificial lung that adds oxygen and removes carbon dioxide, then sends the warmed, oxygenated blood back. The baby's own organs get a chance to rest. They get a chance to heal.
You may have walked into a NICU and seen a baby surrounded by a tangle of tubing the color of dark wine. That is the ECMO circuit. It looks scary. It is scary. It also works. For some of the sickest newborns alive today, ECMO is the reason they are still here.
This guide is for families, students, and clinicians who want to understand how extracorporeal membrane oxygenation applies specifically to newborns — the indications, the criteria, what the tubing looks like in a neck the size of a lemon, what happens day to day, and what the long-term outlook really looks like once the machine comes off. Test your knowledge with the Neonatal and Pediatric ECMO practice test after you finish reading.
Neonatal ECMO began in 1975 when Dr. Robert Bartlett saved a baby named Esperanza in California. Fifty years later, more than 50,000 newborns have been treated with ECMO worldwide. The Extracorporeal Life Support Organization (ELSO) registry now contains data on every one of them, and the picture it paints is hopeful. About 73% of newborns placed on ECMO survive to hospital discharge. That number is staggering when you remember the alternative: babies who go on ECMO have already failed everything else.
Newborn ECMO is not a routine intervention. It is reserved for babies whose lungs or heart have failed in a way that doctors believe is reversible. If the underlying cause is not reversible, ECMO becomes a bridge to nowhere — and most centers will not start it. The five classic neonatal indications are persistent pulmonary hypertension of the newborn, congenital diaphragmatic hernia, meconium aspiration syndrome, severe sepsis, and respiratory failure of other causes such as RDS, pneumonia, or air leak syndromes.
In the womb, blood bypasses the lungs through two shortcuts — the ductus arteriosus and the foramen ovale. After birth, the lungs are supposed to open, the pulmonary arteries are supposed to relax, and the shortcuts are supposed to close. In PPHN, they don't. The lungs stay clamped down. Blood keeps shunting away from them. The baby turns a dusky blue color no matter how much oxygen you give. PPHN is the single most common reason a full-term newborn ends up on ECMO. It accounts for roughly 25% of all neonatal runs.
CDH is a hole in the diaphragm that lets the intestines push up into the chest before birth. The lung on that side never grows properly. The lung on the other side is also small. After delivery, even with the best ventilator, the baby cannot oxygenate. ECMO buys time. The baby is supported on the circuit until the surgical team repairs the hernia and the lungs have a chance to stretch out. CDH babies tend to run longer on ECMO than other newborns — sometimes two to three weeks — and survival is lower, around 50%.
Meconium is the dark, tarry first stool. Babies are not supposed to pass it before they are born. When they do — usually because they are stressed in labor — they can breathe it into their lungs. The meconium is thick, irritating, and full of bile salts. It plugs airways, inactivates surfactant, and triggers pneumonitis. MAS used to be a leading cause of newborn ECMO. Better delivery-room suctioning has cut the numbers, but severe cases still happen and ECMO remains the rescue. Outcomes are excellent — MAS babies have the best survival of any neonatal ECMO group, often above 90%.
Group B Strep, E. coli, and other organisms can crash a newborn within hours. The combination of septic shock and respiratory failure is what tips them toward ECMO. These babies often need veno-arterial ECMO rather than VV, because their hearts are also failing. Survival is lower here, around 50–60%, because the underlying illness is so severe.
This catch-all includes severe RDS in late-preterm babies, viral pneumonia, pulmonary hemorrhage, and air-leak syndromes that have not responded to high-frequency ventilation and inhaled nitric oxide. ECMO is the last stop before death.
Oxygenation index (OI) above 40 on two arterial gases 30–60 minutes apart, or OI above 25 with rapid deterioration. OI is calculated as (mean airway pressure × FiO2 × 100) ÷ PaO2. An OI above 40 means the baby is dying on the ventilator. Other triggers include alveolar-arterial oxygen gradient (AaDO2) above 600 for 8 hours, intractable hypotension despite maximal pressors, or acute deterioration with PaO2 below 40 mm Hg.
Not every sick newborn is a candidate. The selection criteria are strict because ECMO is invasive, expensive, and carries real risks. The classic neonatal ECMO criteria, published by ELSO and used by virtually every center in the world, are these:
Centers also consider family wishes, the team's experience, and the resources available at that hospital. A community NICU without an ECMO program will transport the baby to a Level IV referral center, often by specialized neonatal transport ECMO team if the baby is too unstable to move conventionally.
PPHN, MAS, severe RDS, pneumonia. Heart is working. Best handled by VV ECMO if cannulas fit.
Congenital heart disease pre/post-op, myocarditis. Needs VA ECMO. Cardiac surgery program required.
Septic shock with pulmonary hypertension. Default to VA ECMO for circulatory support plus oxygenation.
CDH stabilization before repair, pulmonary venous obstruction awaiting catheter intervention.
Adults and older children frequently get veno-venous ECMO when their heart is fine and only the lungs are failing. The story is different in newborns. The smallest size of dual-lumen VV cannula on the market is 13 French. It fits a baby of about 3 kg. For babies under 3 kg, VV is not technically possible, and they go on VA whether their heart needs it or not. Even when VV is feasible, many neonatal centers prefer VA because it supports the circulation simultaneously, and sick newborns often have at least some myocardial dysfunction from hypoxia.
VA ECMO in a newborn means cannulating the right common carotid artery and the right internal jugular vein. Yes — the carotid artery in the neck. This is the part that makes families gasp. The cannula goes in through a small neck incision; the surgeon ties off the artery and threads the cannula into the aortic arch. Blood is returned to the body through this arterial cannula at high pressure. Drainage comes through the venous cannula in the IJ, which sits in the right atrium.
Carotid ligation sounds catastrophic but the brain has a backup blood supply through the circle of Willis. When the cannula comes out, surgeons can either tie the artery off permanently or reconstruct it. Long-term studies show the difference in neurologic outcomes is small, but most modern centers attempt repair. The rate of left-sided strokes is slightly higher in babies who had right carotid ligation, though large registry data show overall neurodevelopmental outcomes are similar.
VV cannulation in a newborn uses a single dual-lumen Avalon-style cannula placed in the right IJ, with the tip in the right atrium. Drainage holes are in the SVC and IVC; the return jet aims at the tricuspid valve. The advantage: no carotid sacrifice, blood mixes physiologically, and the heart pumps normally. The disadvantage: recirculation is higher, and the cannula simply does not fit a 2 kg baby.
Neonatal cannulation is a surgical procedure done at the bedside in the NICU or in the operating room. The baby is paralyzed, sedated, and the neck is prepped sterile. A horizontal incision is made above the right clavicle. The carotid artery and internal jugular vein are dissected out and looped. Heparin is given (50–100 units/kg). The vessels are clamped and opened, and the cannulas are inserted.
Cannula sizes: 8–10 Fr arterial, 10–14 Fr venous, depending on baby's weight. The cannulas are designed by companies like Medtronic, Maquet, and historically Bernheim, with thin walls and side holes to maximize flow at small diameters. The cannulas are secured to the skin with thick silk sutures and a clear occlusive dressing. The whole procedure takes 45–90 minutes.
Once on circuit, the baby usually pinks up within minutes. Ventilator settings are dropped to resting parameters — PIP 15, PEEP 5, rate 10, FiO2 30% — to let the lungs rest. A chest X-ray confirms cannula positions. Continuous heparin runs at 20–50 units/kg/hr, titrated to keep activated clotting time (ACT) 180–220 seconds. A head ultrasound is repeated every 24 hours for the first 3 days to catch any bleeding early.
Sedation typically uses fentanyl and midazolam. The baby is generally awake enough to open eyes and respond to mom's voice. Some centers keep babies nearly extubated awake on the circuit, which has been shown to improve neurodevelopmental outcomes.
Once stable, the routine becomes monitoring. Hourly checks on circuit pressures, flows, oxygen saturations, blood gases, and ACTs. Daily labs include CBC, full chemistry, coagulation panel, and lactate. The circuit components — pump, oxygenator, tubing — are inspected for clots. Bleeding sites are watched. Blood and platelet transfusions are common; the average newborn on ECMO receives a unit of blood every other day.
The family is taught how to touch the baby safely around the cannulas, how to read the monitors, and when to step back during procedures. Many ECMO units encourage skin-to-skin contact when stable — yes, even on ECMO.
Weaning starts when the underlying disease improves. For PPHN, this means decreasing oxygen needs and rising native blood pressure. For CDH, it means after the surgical repair and improved lung function. The ventilator is gradually increased back to normal settings while the ECMO flow is lowered. A trial off ECMO is then attempted — the circuit is clamped for 60 minutes while the baby breathes on the ventilator alone. If blood gases hold, the cannulas come out.
Decannulation is another surgical procedure. The carotid is either ligated or reconstructed. The baby goes back to the ventilator for a few days, then is gradually extubated. From cannulation to discharge home is typically 3–6 weeks.
Different hospitals do this differently. Some Level IV NICUs run their own neonatal ECMO program with NICU nurses, neonatologists, and perfusionists managing the baby in the same room where they were born. Others transfer babies to the pediatric cardiac ICU because that is where the cardiac surgeons and ECMO specialists work. Both models work. The data from ELSO show no clear survival advantage of one over the other.
NICU advantages: continuity of nursing, familiar environment for parents, developmentally appropriate care, breastmilk feeding pathways already in place. PICU advantages: deeper ECMO experience, immediate access to cardiac surgery, more nurses cross-trained on the circuit.
What matters most is volume. Centers running fewer than 6 neonatal ECMO cases per year tend to have worse outcomes than centers running 20 or more, regardless of which ICU the baby lives in. If your baby qualifies for ECMO at a low-volume center, it is reasonable to ask whether transfer to a high-volume center is feasible.
If your newborn is being considered for ECMO, the conversation will move fast. The team will explain the risks, the survival statistics for your baby's specific diagnosis, and the alternatives. You will be asked to sign consent. You may not have time to read the form line by line. That is okay — the team will summarize it. Ask whatever you need to ask. There are no stupid questions when you are signing a form to let a machine breathe for your baby.
Within an hour of consent, your baby will be in surgery for cannulation. You will not be in the room. Most centers have a waiting area nearby, with a social worker or chaplain available. Cannulation takes about an hour. You will be able to see your baby again 60–90 minutes after they wheel them out of the room, by which point the circuit is running and the baby is usually a much better color than when they went in.
The first 48 hours are the riskiest. Bleeding can happen, the circuit can fail, and the baby can have a stroke or seizure. The team will be at the bedside almost continuously. You may feel useless, in the way, like you should be doing something. You are doing something — you are present, and presence matters for tiny brains.
Days 3–7 are usually the most stable. By now the bleeding risk is lower, the baby is alert, and you can hold their hand, read to them, even do skin-to-skin in some units. Mom can pump breastmilk; some units will give it via NG tube even on ECMO, which has been shown to reduce gut complications.
Days 7–14 are the weaning window for most babies. PPHN and MAS often come off within 5–7 days. CDH and severe sepsis can run two weeks or longer. If your baby is still on ECMO at day 21, the team will start having harder conversations with you about what comes next.
Survival numbers are reassuring but they only tell half the story. The other half is what happens to the brain. Every newborn placed on ECMO has already survived a profound period of low oxygen, low blood pressure, or both. Add the carotid ligation, the heparin, the inflammatory response from the circuit, and you have a population at real risk for neurodevelopmental problems.
Large multicenter follow-up studies show roughly 25–35% of ECMO survivors have some form of neurodevelopmental impairment at 2–5 years of age. Most impairments are mild — language delay, mild motor delay, attention issues. Severe disability (cerebral palsy, severe cognitive impairment, deafness) occurs in roughly 10–15%. About two-thirds of children come through with neurodevelopmental scores in the normal range.
Risk factors for worse outcomes include CDH diagnosis, longer ECMO runs (over 14 days), bleeding complications during the run, and abnormal neuroimaging before decannulation. Risk factors for better outcomes include MAS or PPHN as the indication, run length under 7 days, and a clean head ultrasound throughout.
Every ECMO survivor should be enrolled in a structured neurodevelopmental follow-up program. These programs do formal assessments at 6 months, 1 year, 2 years, 3–5 years, and school age. Early intervention services — physical therapy, speech therapy, occupational therapy — are often started even before any deficit is detected, because we know the at-risk profile of this group.
The Extracorporeal Life Support Organization registry is the single best source of neonatal ECMO data in the world. It now contains more than 50,000 neonatal cases dating back to the 1980s. The data are updated quarterly and reported transparently by ELSO. Here are the headline numbers from the most recent published summary.
By diagnosis (survival to discharge): Meconium aspiration 93%. PPHN 78%. Air leak syndrome 73%. Sepsis 62%. CDH 50%. Other respiratory 70%.
By mode: VV ECMO 80% survival, VA ECMO 71%. VV looks better, but selection bias is huge — VV babies tend to have milder heart involvement to begin with.
By run length: 1–4 days 78%, 5–10 days 72%, 11–14 days 64%, 15–21 days 51%, over 21 days 34%. Longer runs are worse, mostly because longer runs reflect more severe disease.
By era: Survival has improved modestly over time as circuits became safer and selection improved, but the overall numbers have plateaued in the last decade. The remaining gains will come from better neuroprotection, not better hardware.
Centers report their own data to ELSO and receive annual benchmarking reports. Families considering an ECMO center can sometimes request site-specific data, which is more meaningful than national averages.
Coming off ECMO is not the end of the NICU stay. Most babies need another 2–4 weeks in the NICU after decannulation, sometimes longer if there were complications or if the underlying diagnosis was CDH. Here is what a typical timeline looks like.
Day of decannulation: Baby is back in the ICU bed, still ventilated, still sedated. Heparin is stopped. The neck wound has a fresh dressing. Vital signs are monitored hourly.
Days 1–3 post-decannulation: Sedation is weaned. The baby starts waking up. Ventilator settings continue to come down. Feeds via NG tube usually restart on day 1 or 2.
Days 4–10: Extubation is attempted as soon as the baby can support their own breathing. Many CDH babies need a longer trial on the ventilator. PPHN and MAS babies usually extubate within a week.
Weeks 2–4: Once extubated, the baby moves to nasal cannula or CPAP, then to room air. Oral feeds are introduced — bottle or breast, depending on the baby's strength. A formal swallow study is sometimes needed before oral feeds start, especially after long intubations.
Weeks 4–6: Discharge planning begins. Home oxygen may be needed for some CDH babies. Cardiology, pulmonology, neurology, and neurodevelopmental follow-up are arranged. Car seat tolerance test is done. Hearing screen is repeated — newborns on ECMO have a higher rate of sensorineural hearing loss and should have BAER testing before discharge.
Going home: Most families leave the NICU 4–8 weeks after ECMO. Some, especially CDH families, leave with feeding tubes, oxygen, or medications. Follow-up appointments are stacked tight in the first six months. By 1 year of age most ECMO graduates are doing well and the appointments thin out.
ECMO stands for extracorporeal membrane oxygenation. The machine pulls a newborn's blood out of the body, runs it through an artificial lung that adds oxygen and removes carbon dioxide, warms it, and returns it to the baby. It allows the baby's heart and lungs to rest while the underlying problem — PPHN, CDH, meconium aspiration, sepsis — has time to heal.
Most newborns are on ECMO for 5–10 days. Meconium aspiration cases often wean in 3–5 days. PPHN babies typically run 5–7 days. Congenital diaphragmatic hernia cases can take 10–21 days or longer because the lungs need time to grow after surgical repair.
The overall ELSO registry survival rate to hospital discharge is about 73% for newborns. Survival varies sharply by diagnosis — meconium aspiration is 93%, PPHN 78%, sepsis 60%, and congenital diaphragmatic hernia 50%. Survival depends heavily on the underlying disease, not the ECMO itself.
VA ECMO is more common in newborns because the smallest VV dual-lumen cannula (13 Fr) only fits babies above about 3 kg. VA ECMO uses the right carotid artery and internal jugular vein in the neck. VV is preferred when feasible because it spares the carotid artery and supports more natural blood flow, but the baby has to be big enough.
Standard criteria include gestational age ≥34 weeks, birth weight ≥2 kg, a reversible underlying cause, mechanical ventilation under 10–14 days, no major intracranial bleeding on head ultrasound, and no lethal congenital anomaly. The triggering physiology is usually an oxygenation index above 40 despite maximum ventilator and inhaled nitric oxide therapy.
About 65–75% of neonatal ECMO survivors have normal neurodevelopmental scores at follow-up. Around 10–15% have severe disability — cerebral palsy, significant cognitive delay, or hearing loss. The remaining 20% have milder issues such as language or attention delay. Risk is higher for CDH babies and for those with long runs or bleeding complications. Every survivor should enroll in a neurodevelopmental follow-up program.
It depends on the center. Some centers permanently ligate the carotid at decannulation. Others surgically reconstruct it. Long-term outcome data show small differences in stroke risk later in life but no major difference in overall neurodevelopmental outcomes. The brain's circle of Willis usually provides adequate collateral blood flow even when the carotid is tied off.
In many modern ECMO units, yes. Once cannulas are stable and the baby is past the highest-risk first 48 hours, parents are often invited to do skin-to-skin holding with the bedside team carefully supporting the cannulas. Reading, singing, and gentle touching are encouraged from day one. Breastmilk pumping and tube feeding of breastmilk during the run are also widely supported.